SCHEMBL6205153

SCHEMBL6205153

COc1ccc(N(CCc2cnc(Cl)nc2Cl)C(=O)N[C@H](C)CO[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)cc1

nearest known ligand 0.35

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.35
TP53 P04637 3/20 0.34
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
MAPK14 Q16539 1/20 0.32
RNF4 P78317 1/20 0.32
ALDH1A1 P00352 2/20 0.31
MTNR1A P48039 3/20 0.30
MTNR1B P49286 3/20 0.30
NPSR1 Q6W5P4 1/20 0.30
ACHE P22303 1/20 0.30
LMNA P02545 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5795287 0.92 SMN1; SMN2 (0.38) SMN1; SMN2TP53GAAMAPTMAPK14
SCHEMBL4757853 0.83 MAPK14 (0.35) SMN1; SMN2TP53GAAMAPTMAPK14
SCHEMBL4707014 0.83 MAPK14 (0.35) SMN1; SMN2TP53GAAMAPTMAPK14
SCHEMBL4707017 0.83 MAPK14 (0.35) SMN1; SMN2TP53GAAMAPTMAPK14
SCHEMBL4757107 0.83 MAPK14 (0.35) SMN1; SMN2TP53GAAMAPTMAPK14
SCHEMBL4707388 0.83 MAPK14 (0.35) SMN1; SMN2TP53GAAMAPTMAPK14
SCHEMBL5831107 0.83 PTK2 (0.42) MAPTMTNR1AMTNR1B
SCHEMBL6205797 0.76 GAA (0.45) SMN1; SMN2TP53GAAMAPTRNF4
SCHEMBL6207773 0.75 EPHX2 (0.37) MAPTALDH1A1LMNAKMT2A
SCHEMBL6207367 0.71 LMNA (0.47) SMN1; SMN2TP53GAAMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1560832-A1 PYRIMIDO 4,5-D PYRIMIDINE DERIVATIVES WITH ANTICANCER ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2005-08-10 EP disclosed
WO-2004041822-A1 PYRIMIDO[4,5-D]PYRIMIDINE DERIVATIVES WITH ANTICANCER ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2004-05-21 WO disclosed